0001237899-14-000001.txt : 20140103
0001237899-14-000001.hdr.sgml : 20140103
20140103161017
ACCESSION NUMBER: 0001237899-14-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131231
FILED AS OF DATE: 20140103
DATE AS OF CHANGE: 20140103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powchik Peter
CENTRAL INDEX KEY: 0001377247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 14505823
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-12-31
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001377247
Powchik Peter
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Clinical Development & Reg
Common Stock
2013-12-31
4
M
0
48000.0
30.63
A
73447
D
Common Stock
2013-12-31
4
F
0
5325.0
276.09
D
68122
D
Common Stock
2013-12-31
4
F
0
22007.0
276.09
D
46115
D
Common Stock
2014-01-02
4
S
0
3000.0
272.88
D
43115
D
Common Stock
2014-01-02
4
S
0
5602.0
273.77
D
37513
D
Common Stock
2014-01-02
4
S
0
3777.0
274.69
D
33736
D
Common Stock
2014-01-02
4
S
0
6893.0
276.04
D
26843
D
Common Stock
2014-01-02
4
S
0
1296.0
276.75
D
25547
D
Common Stock
2014-01-02
4
S
0
100.0
277.5
D
25447
D
Common Stock
1589
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
30.63
2013-12-31
4
M
0
48000.0
0.0
D
2020-12-14
Common Stock
48000
4736
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 3,000 shares of Company stock on January 2, 2014 at prices ranging from $272.20 to $273.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price.
Represents volume-weighted average price of sales of 5,602 shares of Company stock on January 2, 2014 at prices ranging from $273.33 to $274.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,777 shares of Company stock on January 2, 2014 at prices ranging from $274.35 to $275.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price.
Represents volume-weighted average price of sales of 6,893 shares of Company stock on January 2, 2014 at prices ranging from $275.46 to $276.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,296 shares of Company stock on January 2, 2014 at prices ranging from $276.48 to $277.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.
/s/**Peter Powchik
2014-01-03